Understanding how immune signaling affects the development of pre-leukemia
Dissecting innate immune signaling in pre-leukemia evolution
This study is looking at how the body's immune system might affect the early stages of pre-leukemia, especially in older adults, to find out what changes can lead to leukemia and to discover new ways to help people at risk of developing this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11042766 on NIH RePORTER |
What this research studies
This research investigates the role of innate immune signaling in the evolution of pre-leukemia, specifically focusing on clonal hematopoiesis (CH), a condition linked to aging. The study aims to identify molecular changes that lead to the transformation of pre-leukemic cells into acute myeloid leukemia (AML). By using advanced techniques like in vivo shRNA screening, researchers will explore how the deletion of specific genes, such as TRAF6, influences the behavior of these pre-leukemic cells. The ultimate goal is to uncover new therapeutic strategies that could improve treatment outcomes for patients at risk of developing leukemia.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults with clonal hematopoiesis who are at increased risk for developing hematologic malignancies.
Not a fit: Patients without clonal hematopoiesis or those who do not have a risk of developing leukemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent the progression of pre-leukemia to acute myeloid leukemia, improving patient outcomes.
How similar studies have performed: Other research has shown promising results in understanding the molecular mechanisms of leukemia, suggesting that this approach could yield valuable insights.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Starczynowski, Daniel — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Starczynowski, Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.